Matthew Gall occupies the position of Chief Financial Officer at iTeos Therapeutics, Inc.

He previously held the position of Vice President-Business Development at Sarepta Therapeutics, Inc.

Mr. Gall received an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.